首页 | 本学科首页   官方微博 | 高级检索  
     


It's time to phase in RHD genotyping for patients with a serologic weak D phenotype
Authors:S. Gerald Sandler  Willy A. Flegel  Connie M. Westhoff  Gregory A. Denomme  Meghan Delaney  Margaret A. Keller  Susan T. Johnson  Louis Katz  John T. Queenan  Ralph R. Vassallo  Clayton D. Simon
Affiliation:1. Department of Pathology and Laboratory Medicine, MedStar Georgetown University Hospital, Washington, DC;2. Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland;3. Immunohematology and Genomics Laboratory, New York Blood Center, New York, New York;4. Diagnostic Laboratories, BloodCenter of Wisconsin, Milwaukee, Wisconsin;5. Red Cell Genomics Laboratory, Puget Blood Center, Seattle, Washington;6. Department of Laboratory Medicine, University of Washington, Seattle, Washington;7. National Molecular Laboratory, American Red Cross Biomedical Services, Philadelphia, Pennsylvania;8. Clinical Education, BloodCenter of Wisconsin, Milwaukee, Wisconsin;9. Medical Office, Americas Blood Centers, Washington, DC;10. Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC;11. Medical Office, American Red Cross Biomedical Services, Philadelphia, Pennsylvania;12. Armed Services Blood Program, Falls Church, Virginia
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号